Using existing FDA-approved drugs to treat osteoarthritis
Official title: Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models
Funded at University of Pittsburgh at Pittsburgh · NIH-10940755 · Data updated 2026-11-12
This study is looking for new ways to use safe, already-approved medications to help people with osteoarthritis not just feel better, but actually improve their condition by targeting specific causes of the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $571,650 |
| NIH project number | 1R01AR084472-01 |
| Project ID | NIH-10940755 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing significant pain and mobility issues.
✕Less likely to help
Patients with osteoarthritis who have already exhausted all FDA-approved treatment options or those with other unrelated joint disorders may not benefit from this research.
What this research studies
This research focuses on finding new uses for FDA-approved drugs to treat osteoarthritis (OA), a painful joint condition affecting millions. By utilizing high-throughput screening in advanced human-like models, the study aims to identify effective treatments that can modify the disease rather than just relieve symptoms. The approach targets specific OA endotypes, which are different biological pathways involved in the disease, to enhance the chances of successful outcomes. This method is advantageous as it leverages existing drugs with known safety profiles, potentially speeding up the treatment development process.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments that not only alleviate pain but also slow or reverse the progression of osteoarthritis.
How similar studies have gone: Previous research has shown promise in repurposing existing drugs for various conditions, indicating that this approach could be effective for osteoarthritis as well.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Lin, Hang — University of Pittsburgh at Pittsburgh
- Study coordinator: Lin, Hang
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.